The role of brain noradrenaline in cortical activation and behavior: A study of lesions of the locus coeruleus, medial thalamus and hippocampus-neocortex and of muscarinic blockade in the rat

Behavioural Brain Research

Volumn 78, Issue 2, 1996, Pages 225-234

  Vanderwolf, C H ^a   Baker, G B ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Behavior; Electrocorticogram; Hippocampus; Noradrenaline; Scopolamine; Thalamus

Indexed keywords

NORADRENALIN; OXIDOPAMINE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; ELECTROCORTICOGRAPHY; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS;

EID: 0030221832     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-4328(95)00253-7     Document Type: Article

References (90)

1. [1] Andén, N.E., Dahlstrom, A., Fuxe, K., Larsson, K., Olson, L. and Ungerstedt, U. Ascending monoamine neurons to the telencephalon and diencephalon, Acta Physiol. Scand., 67 (1966) 313-326.
2. [2] Angeleri, F., Marchesi, G.F. and Quattrini, A. Effects of chronic thalamic lesions on the electrical activity of the neocortex and on sleep. Arch. Ital. Biol., 107 (1969) 633-667.
3. [3] Arendt, T., Bigl, V., Arendt, A. and Tennestedt, A., Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans, and Korsakoff's disease, Acta Neuropathol., 61 (1983) 101-108.
4. [4] Arnsten, A.F.T. and Goldman-Rakic, P.S., Catecholamines and cognitive decline in aged nonhuman primates, Ann. NY Acad. Sci., 444 (1985) 218-234.
5. [5] Aston-Jones, G. and Bloom, F.E., Activity of norepinephrine containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle, J. Neurosci., 1 (1981) 876-886.
6. [6] Aston-Jones, G. and Bloom, F.E., Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli, J. Neurosci., 1 (1981) 887-900.
7. [7] Baker, G.B., Coutts, R.T. and Rao, T.S., Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine, Br. J. Pharmacol., 92 (1987) 243-255.
8. [8] Baraban, J.M. and Aghajanian, G.K., Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoreceptor antagonists, Neuropharmacology, 19 (1980) 355-363.
9. [9] Baust, W., Niemczyk, H. and Vieth, J., The action of blood pressure on the ascending reticular activating system with special reference to adrenaline-induced EEG arousal, Electroenceph. Clin. Neurophysiol., 15 (1963) 63-72.
10. [10] Beaudet, A. and Descarries, L., The monoamine innervation of rat cerebral cortex: synaptic and non-synaptic axon terminals, Neuroscience, 3 (1978) 851-860.
11. [11] Benton, J.S., Bowen, D.M., Allen, S.J., Haan, E.A., Davison, A.N., Neary, D., Murphy, R.P. and Snowden, J.S., Alzheimer's disease as a disorder of isodendritic core, Lancet, i (1982) 456.
12. [12] Berridge, C.W. and Foote, S.L., Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus, J. Neurosci., 11 (1991) 3135-3145.
13. [13] Buzsaki, G. and Gage, F.H., The cholinergic nucleus basalis: a key structure in neocortical arousal, In M. Frotscher and U. Misgeld (Eds.), Central Cholinergic Synaptic Transmission, Basel, Birkhauser Verlag, 1989, pp. 158-171.
14. [14] Buzsaki, G., Kennedy, B., Solt, V.B. and Ziegler, M., Noradrenergic control of thalamic oscillation: the role of α-2 receptors, Eur. J. Neurosci., 3 (1991) 222-229.
15. [15] Cohen, M.L., Serotonin receptors in vascular smooth muscle. In E. Sanders-Bush (Ed), The Serotonin Receptors, Clifton, New Jersey, Humana Press, 1988, pp. 295-316.
16. [16] Collerton, D., Cholinergic function and intellectual decline in Alzheimer's disease, Neuroscience, 19 (1986) 1-28.
17. [17] Cooley, R.K. and Vanderwolf, C.H., Construction of wire leads and electrodes for use in slow wave recording in small animals, Brain Res. Bull., 3 (1978) 175-179.
18. [18] Cordeau, J.P., de Champlain, J. and Jacks, B., Excitation and prolonged waking produced by catecholamines injected into the ventricular system of cats, Can. J. Physiol. Pharmacol., 49 (1971) 627-631.
19. [19] Decker, M.W., Cholinergic/noradrenergic interactions and memory. In E.D. Levin, M.W. Decker and L.L. Butcher (Eds.), Neurotransmitter Interactions and Cognitive Function, Boston, Birkhauser, 1992, pp. 78-90.
20. [20] Decker, M.W. and Gallagher, M., Scopolamine-disruption of radial arm maze performance: modification by noradrenalin depletion, Brain Res., 417 (1987) 59-69.
21. [21] Decker, M.W. and McGaugh, J.L., Effects of concurrent manipulations of cholinergic and noradrenergic function on learning and retention in mice, Brain Res., 477 (1989) 29-37.
22. [22] Dell, P.C., Humoral effects on the brain stem reticular formations. In H.H. Jasper, L.D. Proctor, R.S. Knighton, W.C. Noshay and R.T. Costello (Eds.), Reticular Formation of the Brain, Boston, Little, Brown and Co., 1958, pp. 365-379.
23. 2-adrenoreceptors affect sleep and arousal mechanisms, Br. J. Pharmacol., 90 (1987) 675-685.
24. [24] De Sarro, G.B., Bagetta, G., Ascioti, C., Libri, V. and Nisticò, G., Microinfusion of clonidine and yohimbine into locus coeruleus alters EEG power spectrum: effects of aging and reversal by phosphatidylserine, Br. J. Pharmacol., 95 (1988) 1278-1286.
25. [25] Dickson, C.T. and Vanderwolf, C.H., Animal models of human amnesia and dementia: hippocampal and amygdala ablation compared with serotonergic and cholinergic blockade in the rat, Behav. Brain Res., 41 (1990) 215-227.
26. 1A receptor, Nature, 335 (1988) 358-360.
27. [27] Florio, V., Bianchi, L. and Longo, V.G., A study of the central affects of sympathomimetic drugs: EEG and behavioral investigations on clonidine and naphazoline, Neuropkarmacology, 14 (1975) 707-714.
28. [28] Foote, S.L., Bloom, F.E. and Aston-Jones, G., The nucleus locus coeruleus: new evidence of anatomical and physiological specificity, Physiol. Rev., 63 (1983) 844-914.
29. [29] Fuxe, K., Evidence for the existence of monoamine terminals in the central nervous system, Acta Physiol. Scand Suppl., 247 (1965) 38-85.
30. [30] Hayes, R.L., Jenkins, L.W., and Lyeth, B.G., Neurotransmittermediated mechanisms of traumatic brain injury: acetylcholine and excitatory amino acids. J. Neurotrauma, 9 (1992) S173-187.
31. [31] Herz, A., Uber die Wirkung von Scopolamin, Benactyzin, und Atropin auf das verhalten der Ratte. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmacol., 236 (1959) 110-111.
32. [32] Hilakivi, I., The role of β-and α-adrenoceptors in the regulation of the stages of the sleep-waking cycle in the cat, Brain Res., 277 (1983) 109-118.
33. [33] Jones, B.E., Bobillier, P., Pin, C. and Jouvet, M., The effect of lesions of catecholamine-containing neurons upon monoamine content of the brain and EEG and behavioral waking in the cat, Brain Res., 58 (1973) 157-177.
34. [34] Jones, R.E., Harper, S.T. and Halaris, A.E., Effect of locus coeruleus lesions upon cerebral monoamine content, sleep-wakefulness states and the response to amphetamine in the cat, Brain Res., 124 (1977) 473-496.
35. [35] Kenny, J.F. and Keeping, E.S., Mathematics of Statistics, Toronto, Van Nostrand, 1954.
36. 1-adrenoceptor blocker prazocin on EEG sleep and waking stages in the rat, Neuropsychobiology, 21 (1989) 100-103.
37. [38] Levitt, P. and Moore, R.Y., Noradrenaline neuron innervation of the neocortex in the rat, Brain Res., 139 (1978), 219-231.
38. [39] Lidbrink, P, The effects of lesions of the ascending noradrenaline pathways on sleep and waking in the rat, Brain Res., 74 (1974) 19-40.
39. [40] Lidov, H.G.W., Grzanna, R. and Molliver, M.E., The serotonin innervation of the cerebral cortex in the rat - An immunohisto-chemical analysis, Neuroscience, 5 (1980) 207-227.
40. [41] Lindvall, O. and Bjorklund, A., The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method, Acta. Physiol. Scand. (Suppl.) 412 (1974) 1-48.
41. [42] Loizou, L.A., Projections of the nucleus locus coeruleus in the albino rat, Brain Res., 15 (1969) 563-566.
42. [43] Loughlin, S.E., Foote, S.L. and Fallen, J.H., Locus coeruleus projections to cortex: topography, morphology, and collateralization, Brain Res. Bull., 9 (1982) 287-294.
43. [44] Loy, R., Koziell, D.A., Lindsey, J.D. and Moore, R.Y., Noradrenergic innervation of the adult rat hippocampal formation, J. Comp. Neurol., 189 (1980) 699-710.
44. [45] Macht, D.I., A pharmacodynamic analysis of the cerebral effects of atropine, homatropin, scopolamin and related drugs, J. Pharmacol. Exp. Ther., 22 (1924) 35-48.
45. [46] Makela, J.P. and Hilakivi, I.T., Effects of alpha-adrenoreceptor blockade on sleep and wakefulness in the rat, Pharmacol. Biochem. Behav., 24 (1986) 613-616.
46. [47] Mantegazzini, P. and Glasser, A., Action de la DL-3-4-dioxyphenilalanine (DOPA) et la dopamine sur l'activité électrique du chat 'cerveau isolé', Arch. Ital. Biol., 98 (1960) 351-366.
47. [48] McCormick, D.A., Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity, Progr. Neurobiol., 39 (1992) 337-388.
48. [49] Morrison, J.H. and Foote, S.L., Noradrenergic and serotoninergic innervation of cortical, thalamic, and tectal visual structures in old and new world monkeys, J. Comp. Neurol., 243 (1986) 117-138.
49. [50] Morrison, J.H., Grzanna, R., Molliver, M.E. and Coyle, J.T., The distribution and orientation of noradrenergic fibers in neocortex of the rat: an immunofluorescence study, J. Comp. Neurol., 181 (1978) 17-40.
50. [51] Morrison, J.H., Molliver, M.E., Grzanna, R. and Coyle, J.T., The intra-cortical trajectory of the coerulo-cortical projection in the rat: a tangentially organized cortical afferent, Neuroscience, 6 (1981) 139-158.
51. 2) receptor mediates enhancement of cortical unit activity, Can. J. Physiol. Pharmacol., 70 (1992) 1604-1609.
52. [53] Nilsson, O.G., Strecker, R.E., Daszuta, A. and Bjorklund, A., Combined cholinergic and serotonergic denervation of the forebrain produces severe deficits in spatial learning in the rat, Brain Res., 453 (1988) 235-246.
53. [54] Normile, H.J. and Altman, H.J., Serotonin influences on cholinergic function: possible interactions in learning and memory. In E.D. Levin, M.W. Decker and L.L. Butcher (Eds.), Neurotransmitter Interactions and Cognitive Function, Boston, Birkhauser, 1992, pp. 207-227.
54. [55] Norusis, M.J., Advanced statistics SPSS/PC+ for the IBM PC/ XT/AT., Chicago, ILL, SPSS Inc.
55. [56] O'Hearn, E. and Molliver, M.E., Organization of raphe-cortical projections in rat: a quantitative retrograde study, Brain Res. Bull., 13 (1984) 709-726.
56. [57] Palmer, A.M., Wilcock, G.K., Esiri, M.M., Francis, P.T. and Bowen, D.M., Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease, Brain Res., 401 (1987) 231-238.
57. 3H]5-hydroxytryptamine, Neuroscience, 6 (1981) 115-138.
58. [59] Paxinos, G. and Watson, C., The rat brain in stereotaxic coordinates, Sydney, Academic Press, 2nd Edn., 1986.
59. [60] Pellejero, T., Monti, J.M., Baglietto, J., Jantos, H., Pazos, S., Cichevski, V. and Hawkins, M., Effects of methoxamine and α-adrenoceptor antagonists, prazocin and yohimbine, on the sleep-wake cycle of the rat, Sleep, 7 (1984) 365-372.
60. [61] Pickel, V.M., Joh, T.H. and Reis, D.J., Monoamine synthesising enzymes in central dopaminergic, noradrenergic, and serotonergic neurons: Immunochemical localization by light and electron microscopy, J. Histochem. Cytochem., 24 (1976) 792-806.
61. [62] Pontecorvo, M.J., Clissold, D.B. and Conti, L.H., Age-related cognitive impairments as assessed with an automated repeated measures memory task: implications for the possible role of acetylcholine and norepinephrine in memory dysfunction, Neurobiol. Aging, 9 (1989) 617-625.
62. [63] Prior, P., Cholinergic-Noradrenergic and Cholinergic-Serotonergic Interactions in Measures of Working and Reference Memory of the Rat, Unpublished Ph.D. thesis, University of Western Ontario, London, Ontario, Canada, 1991.
63. 2 receptors facilitates depolarization of neocortical neurons by N-methyl-D-asparate, Eur. J. Pharmacol., 231 (1993) 347-354.
64. [65] Richter-Levin, G. and Segal, M., Spatial performance is severely impaired in rats with combined reduction of serotonergic and cholinergic transmission, Brain Res., 477 (1989) 404-407.
65. [66] Riekkinen, P. Jr., Sirvio, J., Valjakka, A., Pitkanen, A., Partanen, J. and Riekkinen, P., The effects of concurrent manipulations of cholinergic and noradrenergic systems on neocortical EEG and spatial learning, Behav. Neurol. Biol., 54 (1990) 204-210.
66. [67] Robinson, T.E., Castaneda, E., & Whishaw, I.Q., Effects of cortical serotonin depletion induced by 3, 4-methylenedioxymethamphetamine (MDMA) on behavior, before and after additional cholinergic blockade. Newopsychopharmacology, 8 (1993) 77-85.
67. [68] Robinson, T.E., Vanderwolf, C.H. and Pappas, B.A., Are the dorsal noradrenergic bundle projections from the locus coeruleus important for neocortical or hippocampal activation? Brain Res., 8 (1977) 75-98.
68. [69] Rossor, M. and Iversen, L.L., Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease, Br. Med. Bull., 42(1) (1986) 70-74.
69. [70] Rothballer, A.B., Studies on the adrenaline-sensitive component of the reticular activating system, Electroenceph. Clin. Neurophysiol., 8 (1956) 603-621.
70. [71] Servos, P., Barke, K.E., Hough, L.B. and Vanderwolf, C.H., Histamine does not play an essential role in electrocortical activation during waking behavior, Brain Res., 636 (1994) 98-102.
71. [72] Siegel, S., Non-parametric Statistics for the Behavioral Sciences, McGraw Hill, New York, 1956.
72. [73] Spangler, E.L., Wenk, G.L., Chachich, M.E., Smith, K. and Ingram, D.K., Complex maze performance in rats: effects of noradrenergic depletion and cholinergic blockade, Behav. Neurosci., 104 (1990) 410-417.
73. [74] Steinbusch, H.W.M., Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals, Neuroscience, 6 (1981) 557-618.
74. [75] Stewart, D.J., MacFabe, D.F. and Vanderwolf, C.H., Cholinergic activation of the electrocorticogram: Role of the substantia innominata and effects of atropine and quinuclidinyl benzilate, Brain Res., 322 (1984) 219-232.
75. [76] Swanson, L.W. and Hartman, B.K., The central adrenergic system: an immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-β-hydroxylase as a marker, J. Comp. Neurol., 163 (1975) 467-506.
76. [77] Vanderwolf, C.H., Near-total loss of 'learning' and "memory" as a result of combined cholinergic and serotonergic blockade in the rat, Behav. Brain Res., 23 (1987) 43-57.
77. [78] Vanderwolf, C.H., Cerebral activity and behavior: control by central cholinergic and serotonergic systems, Int. Rev. Neurobiol., 30 (1988) 225-340.
78. [79] Vanderwolf, C.H., Anti-muscarinic drug effects in a swim-to-platform test: dose-response relations, Behav. Brain Res., 44 (1991) 217-219.
79. [80] Vanderwolf, C.H. and Baker, G.B., Evidence that serotonin mediates non-cholinergic neocortical low voltage fast activity, non-cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior, Brain Res., 374 (1986) 342-356.
80. [81] Vanderwolf, C.H., Baker, G.B. and Dickson, C., Serotonergic control of cerebral activity and behavior: models of dementia, Ann. NY Acad. Sci., 600 (1990) 366-383.
81. [82] Vanderwolf, C.H. and Cain, D.P., The behavioral neurobiology of learning and memory: a conceptual reorientation, Brain Res Rev., 19 (1994) 264-297.
82. [83] Vanderwolf, C.H., Dickson, C.T. and Baker, G.B., Effects of p-chlorophenylalanine and scopolamine on retention of habits in rats, Pharmacol. Biochem. Behav., 35 (1990) 847-853.
83. [84] Vanderwolf, C.H., Leung, L.-W.S., Baker, G.B. and Stewart, D.J., The role of serotonin in the control of cerebral activity: studies with intracerebral 5,7-dihydroxytryptamine, Brain Res., 504 (1989) 181-191.
84. [85] Vanderwolf, C.H. and Penava, D., Potentiation of the effects of antimuscarinic drugs on behavior by serotonin depletion: specificity and relation to learning and memory. In E.D. Levin, M.W. Decker and L.L. Butcher (Eds.), Neurotransmitter Interactions and Cognitive Function, Boston, Birkhauser, 1992, pp. 257-276.
85. [86] Vanderwolf, C.H. and Stewart, D.J., Thalamic control of neocortical activation: a critical re-evaluation, Brain Res. Bull, 20 (1988) 529-538.
86. [87] Victor, M., Adams, R.D. and Collins, G.H. The Wernicke-Korsakoff Syndrome and Related Neurologic Disorders Due to Alcoholism and Malnutrition, 2nd Edn., Philadephia, F.A. Davis Co, 1989.
87. [88] Watson, N.V., Hargreaves, E.L., Penava, D., Eckel, L.A. and Vanderwolf, C.H., Serotonin-dependent cerebral activation: effects of methiothepin and other serotonergic antagonists, Brain Res., 597 (1992) 16-23.
88. [89] Whishaw, I.Q., O'Connor, W.T. and Dunnett, S.B., Disruption of central cholinergic systems in the rat by basal forebrain lesions or atropine: effects on feeding, sensorimotor behavior, locomotor activity, and spatial navigation. Behav. Brain Res., 17 (1985) 103-115.
89. [90] Whishaw, I.Q., Robinson, T.E., Schallert, T., De Ryck, M. and Ramirez, V.D., Electrical activity of the hippocampus and neocortex in rats depleted of brain dopamine and norepinephrine: Relations to behavior and effects of atropine, Exp. Neurol., 62 (1978) 748-767.
90. [91] Zornetzer, S.F., Catecholamine system involvement in age-related memory dysfunction, Ann. NY Acad. Sci., 444 (1985) 242-254.